{'fraction_non_alphanumeric': 0.01592920353982301, 'fraction_numerical': 0.0, 'mean_word_length': 6.1645569620253164, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Outcomes of lactulose plus branched‐chain amino acid infusion and lactulose alone for hepatic encephalopathy: A retrospective cohort study using a national inpatient database

Previous randomized controlled trials of branched‐chain amino acid infusion for hepatic encephalopathy involved a small number of patients, and the effectiveness of branched‐chain amino acid infusion has not been clarified. We evaluated whether branched‐chain amino acid infusion in addition to lactulose treatment was associated with short‐term outcomes in a large population of patients.